Not applicableUnknownNCT02506452What this trial is testingPostmarket Study to Evaluate Biovance® in Diabetic Foot UlcersWho this might be right forDiabetic Foot Ulcers Alliqua BioMedical, Inc 51
Large-scale testing (Phase 3)Study completedNCT03281538What this trial is testingExtension Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe PruritusWho this might be right forUremic Pruritus Cara Therapeutics, Inc. 288
Large-scale testing (Phase 3)Study completedNCT01406938What this trial is testingEfficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose RegimensWho this might be right forModerate to Severe Plaque-type Psoriasis Novartis Pharmaceuticals 967
Not applicableStudy completedNCT00702858What this trial is testingTrial of Blue Citrus Compared to Placebo in Patients Receiving Aromatase Inhibitor Therapy for Estrogen Receptor Positive Post-Menopausal Breast CancerWho this might be right forBreast CancerJoint Pain Legacy Health System 30
Early research (Phase 1)Ended earlyNCT04504435What this trial is testingSafety, Tolerability and Pharmacokinetics (PK) Investigation of GSK3494245 in Healthy ParticipantsWho this might be right forLeishmaniasis GlaxoSmithKline 59
Not applicableWithdrawnNCT02486848What this trial is testingMinoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical MinoxidilWho this might be right forFemale Pattern Hair LossAndrogenetic Alopecia Maja Kovacevic, MD
Large-scale testing (Phase 3)Study completedNCT06224348What this trial is testingEvaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical CorticosteroidsWho this might be right forDermatitis Atopic Sanofi 643
Early research (Phase 1)Study completedNCT05405985What this trial is testingStudy to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber SyringeWho this might be right forHealthy Volunteers Galderma R&D 192
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07826052What this trial is testingChemotherapy Exemption in Elderly Women With Node-Positive ER+/HER2- Breast CancerWho this might be right forBreast CancerAdjuvant Therapy Fudan University 494
Large-scale testing (Phase 3)Study completedNCT01651949What this trial is testingMultivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)Who this might be right forGenital WartsAnal CancerAnal Intraepithelial Neoplasia Merck Sharp & Dohme LLC 2,520
Large-scale testing (Phase 3)Ended earlyNCT02202135What this trial is testingEvaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections.Who this might be right forComplicated Skin and Soft Tissue Infection Pfizer 4
Large-scale testing (Phase 3)Study completedNCT00102336What this trial is testingAMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to SplenectomyWho this might be right forThrombocytopeniaIdiopathic Thrombocytopenic Purpura Amgen 62
Not applicableUnknownNCT05845632What this trial is testingTime to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell CarcinomaWho this might be right forCarcinoma, Squamous CellSkin CancerCarcinoma, Squamous Cell, Skin+3 more Maastricht University Medical Center 965
Post-approval studies (Phase 4)Study completedNCT01722214What this trial is testingTrial on the Effect of Adalimumab on Vascular Inflammation in Patients With PsoriasisWho this might be right forPsoriasisVascular InflammationCoronary Atherosclerosis Innovaderm Research Inc. 107
Early research (Phase 1)Study completedNCT01549054What this trial is testingA Study in Healthy Subjects to Evaluate Bioavailability of 4 Formulations of E5501Who this might be right forIdiopathic Thrombocytopenic Purpura Eisai Inc. 28
Testing effectiveness (Phase 2)Looking for participantsNCT05588453What this trial is testingNatural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the BrainWho this might be right forClinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic Melanoma+1 more Kari Kendra 24
Not applicableActive Not RecruitingNCT06598137What this trial is testingStudy to Examine Lesions of the Skin Using Confocal Laser MicroscopyWho this might be right forBenign Skin TumorBasal Cell CarcinomaMelanoma+1 more LMU Klinikum 645
Not applicableUnknownNCT03025139What this trial is testingMindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness)Who this might be right forCancer SurvivorEarly-Stage Breast CarcinomaStage 0 Breast Cancer+7 more Jonsson Comprehensive Cancer Center 96
Testing effectiveness (Phase 2)WithdrawnNCT00397501What this trial is testingBBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the BrainWho this might be right forBrain and Central Nervous System TumorsBreast CancerCognitive/Functional Effects+2 more OHSU Knight Cancer Institute
Early research (Phase 1)WithdrawnNCT05905341What this trial is testingStudy of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.Who this might be right forBreast CancerOvarian CancerLiposarcoma+3 more Pfizer